Wednesday, August 5, 2020
The study analyzed data from a Finnish national cancer registry along with prescription drug claims for over 10,000 women between 1995 and 2015. The researchers found that women with all subtypes of ovarian cancer had a lower mortality rate if they took statins.
Although more research needs to be done, statins are very well tolerated and inexpensive and may prove to be part of the armament of treatment protocols at some point in the future.
To read more about this study, follow this link.